Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Anti-PD-1 Antibody industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Abbvie
Novartis
Bristol-Myers Squibb (BMS)
Chugai Pharmaceutical Co, Ltd
Sino Biological Inc
Ono Pharmaceutical Co, Ltd
Arcus Biosciences
Bio X Cell
TG Therapeutics, Inc
InvivoGen
Lilly
Abcam
BioVision Inc
Thermo Fisher
By Type:
Polyclonal
Monoclonal
By Application:
ELISA
IHC-P
Flow Cytometry
WB
ICC/IF
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Anti-PD-1 Antibody Market Overview 2018-2029
-
1.1 China Anti-PD-1 Antibody Industry Development Overview
-
1.2 China Anti-PD-1 Antibody Industry Development History
-
1.3 China Anti-PD-1 Antibody Industry Market Size (2018-2029)
-
1.4 China Anti-PD-1 Antibody Market Analysis by Type from Production Side
-
1.4.1 China Anti-PD-1 Antibody Production Volume, Production Value and Growth Rate of Polyclonal (2018-2029)
-
1.4.2 China Anti-PD-1 Antibody Production Volume, Production Value and Growth Rate of Monoclonal (2018-2029)
-
1.5 China Anti-PD-1 Antibody Market Analysis by Application from Consumption End
-
1.5.1 China Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate of ELISA (2018-2029)
-
1.5.2 China Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate of IHC-P (2018-2029)
-
1.5.3 China Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate of Flow Cytometry (2018-2029)
-
1.5.4 China Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate of WB (2018-2029)
-
1.5.5 China Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate of ICC/IF (2018-2029)
-
1.6 China Anti-PD-1 Antibody Market Analysis by Region
-
1.6.1 North China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
Chapter 2 China Anti-PD-1 Antibody Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Anti-PD-1 Antibody Market Status and Competition at home and abroad in 2023
-
2.2.2 China Anti-PD-1 Antibody Market Status and Competition Analysis in 2023
-
2.2.3 China Anti-PD-1 Antibody Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Anti-PD-1 Antibody Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Anti-PD-1 Antibody Industry Development
Chapter 3 Anti-PD-1 AntibodyIndustry Chain Analysis
-
3.1 Anti-PD-1 Antibody Industry Chain
-
3.2 Anti-PD-1 Antibody Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Anti-PD-1 Antibody Market
-
3.3 Anti-PD-1 Antibody Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Anti-PD-1 Antibody Market
Chapter 4 China Anti-PD-1 Antibody Market, by Type
-
4.1 China Anti-PD-1 Antibody Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Anti-PD-1 Antibody Total Production Volume and Growth Rate from Production Side
-
4.5 China Anti-PD-1 Antibody Production Volume and Growth Rate, by Type
-
4.5.1 China Anti-PD-1 Antibody Production Volume and Growth Rate of Polyclonal
-
4.5.2 China Anti-PD-1 Antibody Production Volume and Growth Rate of Monoclonal
Chapter 5 China Anti-PD-1 Antibody Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Anti-PD-1 Antibody Total Market Size and Growth Rate from Consumption End
-
5.5 China Anti-PD-1 Antibody Market Size and Growth Rate, by Application
-
5.5.1 China Anti-PD-1 Antibody Market Size and Growth Rate of ELISA
-
5.5.2 China Anti-PD-1 Antibody Market Size and Growth Rate of IHC-P
-
5.5.3 China Anti-PD-1 Antibody Market Size and Growth Rate of Flow Cytometry
-
5.5.4 China Anti-PD-1 Antibody Market Size and Growth Rate of WB
-
5.5.5 China Anti-PD-1 Antibody Market Size and Growth Rate of ICC/IF
Chapter 6 China Anti-PD-1 Antibody Market, by Region
-
6.1 China Anti-PD-1 Antibody Production Volume and Production Value, by Region
-
6.2 China Anti-PD-1 Antibody Sales Volume and Sales Value, by Region
Chapter 7 North China Anti-PD-1 Antibody Market Analysis
-
7.1 North China Anti-PD-1 Antibody Market, by Type
-
7.2 North China Anti-PD-1 Antibody Market, by Application
Chapter 8 Central China Anti-PD-1 Antibody Market Analysis
-
8.1 Central China Anti-PD-1 Antibody Market, by Type
-
8.2 Central China Anti-PD-1 Antibody Market, by Application
Chapter 9 South China Anti-PD-1 Antibody Market Analysis
-
9.1 South China Anti-PD-1 Antibody Market, by Type
-
9.2 South China Anti-PD-1 Antibody Market, by Application
Chapter 10 East China Anti-PD-1 Antibody Market Analysis
-
10.1 East China Anti-PD-1 Antibody Market, by Type
-
10.2 East China Anti-PD-1 Antibody Market, by Application
Chapter 11 Northeast China Anti-PD-1 Antibody Market Analysis
-
11.1 Northeast China Anti-PD-1 Antibody Market, by Type
-
11.2 Northeast China Anti-PD-1 Antibody Market, by Application
Chapter 12 Southwest China Anti-PD-1 Antibody Market Analysis
-
12.1 Southwest China Anti-PD-1 Antibody Market, by Type
-
12.2 Southwest China Anti-PD-1 Antibody Market, by Application
Chapter 13 Northwest China Anti-PD-1 Antibody Market Analysis
-
13.1 Northwest China Anti-PD-1 Antibody Market, by Type
-
13.2 Northwest China Anti-PD-1 Antibody Market, by Application
Chapter 14 Company Profiles
-
14.1 Abbvie
-
14.1.1 Abbvie Company Profile
-
14.1.2 Abbvie Anti-PD-1 Antibody Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Novartis
-
14.2.1 Novartis Company Profile
-
14.2.2 Novartis Anti-PD-1 Antibody Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Bristol-Myers Squibb (BMS)
-
14.3.1 Bristol-Myers Squibb (BMS) Company Profile
-
14.3.2 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Chugai Pharmaceutical Co, Ltd
-
14.4.1 Chugai Pharmaceutical Co, Ltd Company Profile
-
14.4.2 Chugai Pharmaceutical Co, Ltd Anti-PD-1 Antibody Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Sino Biological Inc
-
14.5.1 Sino Biological Inc Company Profile
-
14.5.2 Sino Biological Inc Anti-PD-1 Antibody Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Ono Pharmaceutical Co, Ltd
-
14.6.1 Ono Pharmaceutical Co, Ltd Company Profile
-
14.6.2 Ono Pharmaceutical Co, Ltd Anti-PD-1 Antibody Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Arcus Biosciences
-
14.7.1 Arcus Biosciences Company Profile
-
14.7.2 Arcus Biosciences Anti-PD-1 Antibody Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Bio X Cell
-
14.8.1 Bio X Cell Company Profile
-
14.8.2 Bio X Cell Anti-PD-1 Antibody Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 TG Therapeutics, Inc
-
14.9.1 TG Therapeutics, Inc Company Profile
-
14.9.2 TG Therapeutics, Inc Anti-PD-1 Antibody Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 InvivoGen
-
14.10.1 InvivoGen Company Profile
-
14.10.2 InvivoGen Anti-PD-1 Antibody Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Lilly
-
14.11.1 Lilly Company Profile
-
14.11.2 Lilly Anti-PD-1 Antibody Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Abcam
-
14.12.1 Abcam Company Profile
-
14.12.2 Abcam Anti-PD-1 Antibody Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 BioVision Inc
-
14.13.1 BioVision Inc Company Profile
-
14.13.2 BioVision Inc Anti-PD-1 Antibody Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Thermo Fisher
-
14.14.1 Thermo Fisher Company Profile
-
14.14.2 Thermo Fisher Anti-PD-1 Antibody Market Performance
-
14.14.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Anti-PD-1 Antibody Industry Research Conclusions
-
15.2 Anti-PD-1 Antibody Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Anti-PD-1 Antibody Industry Market Size (2018-2029)
-
Figure China Anti-PD-1 Antibody Production Volume, Production Value and Growth Rate of Polyclonal (2018-2029)
-
Figure China Anti-PD-1 Antibody Production Volume, Production Value and Growth Rate of Monoclonal (2018-2029)
-
Figure China Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate of ELISA (2018-2029)
-
Figure China Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate of IHC-P (2018-2029)
-
Figure China Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate of Flow Cytometry (2018-2029)
-
Figure China Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate of WB (2018-2029)
-
Figure China Anti-PD-1 Antibody Sales Volume, Sales Value and Growth Rate of ICC/IF (2018-2029)
-
Figure North China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
Figure Central China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
Figure South China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
Figure East China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Anti-PD-1 Antibody Market Size and Growth Rate from 2018-2029
-
Figure Anti-PD-1 Antibody Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Anti-PD-1 Antibody Market Share by Type in 2018
-
Figure China Anti-PD-1 Antibody Market Share by Type in 2023
-
Figure China Anti-PD-1 Antibody Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Anti-PD-1 Antibody Production Volume and Growth Rate of Polyclonal (2018-2023)
-
Figure China Anti-PD-1 Antibody Production Volume and Growth Rate of Monoclonal (2018-2023)
-
Figure China Anti-PD-1 Antibody Market Share by Application in 2018
-
Figure China Anti-PD-1 Antibody Market Share by Application in 2023
-
Figure China Anti-PD-1 Antibody Total Market Size and Growth Rate from Consumption End
-
Figure China Anti-PD-1 Antibody Market Size and Growth Rate of ELISA (2018-2023)
-
Figure China Anti-PD-1 Antibody Market Size and Growth Rate of IHC-P (2018-2023)
-
Figure China Anti-PD-1 Antibody Market Size and Growth Rate of Flow Cytometry (2018-2023)
-
Figure China Anti-PD-1 Antibody Market Size and Growth Rate of WB (2018-2023)
-
Figure China Anti-PD-1 Antibody Market Size and Growth Rate of ICC/IF (2018-2023)
-
Table China Anti-PD-1 Antibody Production Volume by Region (2018-2023)
-
Table China Anti-PD-1 Antibody Production Volume Share by Region (2018-2023)
-
Figure China Anti-PD-1 Antibody Production Volume Share by Region (2018-2023)
-
Table China Anti-PD-1 Antibody Production Value by Region (2018-2023)
-
Table China Anti-PD-1 Antibody Production Value Share by Region (2018-2023)
-
Figure China Anti-PD-1 Antibody Production Value Share by Region (2018-2023)
-
Table China Anti-PD-1 Antibody Sales Volume by Region (2018-2023)
-
Table China Anti-PD-1 Antibody Sales Volume Share by Region (2018-2023)
-
Figure China Anti-PD-1 Antibody Sales Volume Share by Region (2018-2023)
-
Table China Anti-PD-1 Antibody Sales Value by Region (2018-2023)
-
Table China Anti-PD-1 Antibody Sales Value Share by Region (2018-2023)
-
Figure China Anti-PD-1 Antibody Sales Value Share by Region (2018-2023)
-
Table North China Anti-PD-1 Antibody Production Volume by Type (2018-2023)
-
Table North China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Figure North China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Table North China Anti-PD-1 Antibody Sales Volume by Application (2018-2023)
-
Table North China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Figure North China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Table Central China Anti-PD-1 Antibody Production Volume by Type (2018-2023)
-
Table Central China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Figure Central China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Table Central China Anti-PD-1 Antibody Sales Volume by Application (2018-2023)
-
Table Central China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Figure Central China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Table South China Anti-PD-1 Antibody Production Volume by Type (2018-2023)
-
Table South China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Figure South China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Table South China Anti-PD-1 Antibody Sales Volume by Application (2018-2023)
-
Table South China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Figure South China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Table East China Anti-PD-1 Antibody Production Volume by Type (2018-2023)
-
Table East China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Figure East China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Table East China Anti-PD-1 Antibody Sales Volume by Application (2018-2023)
-
Table East China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Figure East China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Table Northeast China Anti-PD-1 Antibody Production Volume by Type (2018-2023)
-
Table Northeast China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Figure Northeast China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Table Northeast China Anti-PD-1 Antibody Sales Volume by Application (2018-2023)
-
Table Northeast China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Table Southwest China Anti-PD-1 Antibody Production Volume by Type (2018-2023)
-
Table Southwest China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Figure Southwest China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Table Southwest China Anti-PD-1 Antibody Sales Volume by Application (2018-2023)
-
Table Southwest China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Table Northwest China Anti-PD-1 Antibody Production Volume by Type (2018-2023)
-
Table Northwest China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Figure Northwest China Anti-PD-1 Antibody Production Volume Share by Type (2018-2023)
-
Table Northwest China Anti-PD-1 Antibody Sales Volume by Application (2018-2023)
-
Table Northwest China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Anti-PD-1 Antibody Sales Volume Share by Application (2018-2023)
-
Table Abbvie Company Profile
-
Table Abbvie Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb (BMS) Company Profile
-
Table Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table Chugai Pharmaceutical Co, Ltd Company Profile
-
Table Chugai Pharmaceutical Co, Ltd Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table Sino Biological Inc Company Profile
-
Table Sino Biological Inc Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table Ono Pharmaceutical Co, Ltd Company Profile
-
Table Ono Pharmaceutical Co, Ltd Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table Arcus Biosciences Company Profile
-
Table Arcus Biosciences Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table Bio X Cell Company Profile
-
Table Bio X Cell Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table TG Therapeutics, Inc Company Profile
-
Table TG Therapeutics, Inc Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table InvivoGen Company Profile
-
Table InvivoGen Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table Lilly Company Profile
-
Table Lilly Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table Abcam Company Profile
-
Table Abcam Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table BioVision Inc Company Profile
-
Table BioVision Inc Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
Table Thermo Fisher Company Profile
-
Table Thermo Fisher Anti-PD-1 Antibody Revenue, Price and Gross (2018-2023)
-
